26580-1

Carnosine/Creatinine [Molar ratio] in Urine

Active

Part Descriptions

LP15476-2 Carnosine
Carnosine (beta -alanyl-L-histidine) is a dipeptide of the amino acids beta -alanine and histidine. It is highly concentrated in muscle and brain tissues. Studies have shown that it can be used as an effective dietary supplement for people with autism, potentially improving such areas as auditory processing, speech language skills, motor skills, and socialization. However, supplemental carnosine may increase corticosterone levels, which can explain the hyperactivity sometimes seen in high doses. Researchers in Australia, Britain, and Russia have also shown that carnosine has a number of antioxidant properties that may be beneficial. Carnosine has been proven to scavenge ROS (radical oxygen species) as well as alpha-beta unsaturated aldehydes formed from peroxidation of cell membrane fatty acids during oxidative stress. It can oppose glycation and it can chelate divalent metal ions. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Carnosine (Wikipedia)

LP32035-5 Creatinine
Creatinine or creatine anhydride, is a breakdown product of creatine phosphate in muscle. The loss of water molecule from creatine results in the formation of creatinine. It is transferred to the kidneys by blood plasma, whereupon it is eliminated by glomular filtration and partial tubular excretion. Creatinine is usually produced at a fairly constant rate and measuring its serum level is a simple test. A rise in blood creatinine levels is observed only with marked damage to functioning nephrons; therefore this test is not suitable for detecting early kidney disease. Creatine and creatinine are metabolized in the kidneys, muscle, liver and pancreas. Copyright Copyright ©2005-2009 Genome Alberta (Reference to original publication: Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 37(Database issue):D603-610.) Source: Human Metabolome Database, Creatinine

LOINC Names Get Info

Fully-Specified Name: Carnosine/Creatinine:SRto:Pt:Urine:Qn:
Long Common Name: Carnosine/Creatinine [Molar ratio] in Urine
Short Name: Carnosine/Creat Ur-sRto
Display Name: Carnosine/Creatinine (U) [Molar ratio]
Consumer Name Alpha Get Info: Carnosine/Creatinine, Urine

Part Model Get Info

Component
Carnosine/Creatinine
LP285232-7
- Analyte
  Carnosine/Creatinine
  LP285232-7
  - Component Numerator
    Carnosine
    LP15476-2
    - Component Numerator Core
      Carnosine
      LP15476-2
    - Component Numerator Core Suffix
      NULL
  - Component Denominator
    Creatinine
    LP32035-5
    - Component Denominator Core
      Creatinine
      LP32035-5
    - Component Denominator Core Suffix
      NULL
- Challenge
  NULL
- Adjustment
  NULL
- Count
  NULL
Property
SRto
LP6868-6
Time
Pt
LP6960-1
- Time Core
  Pt
  LP6960-1
- Time Modifier
  NULL
System
Urine
LP7681-2
- System Core
  Urine
  LP7681-2
- Super System
  NULL
Scale
Qn
LP7753-9
Method
NULL

Basic Attributes

Class: CHEM
Type: Laboratory
First Released: Version 2.00
Last Updated: Version 2.73 (MIN)
Order vs. Observation: Observation
Common Test Rank Get Info: 18474

Member of these Panels

LOINC	Long Common Name
74991-1	Amino acids panel [Molar ratio] - Urine

Member of these Groups Get Info

LOINC Group	Group Name
LG35428-8	Carnosine/Creatinine\|SRto\|Urine

Language Variants Get Info

Tag	Language	Translation
cs-CZ	Czech (Czechia)	Karnosin/kreatinin:Látkový poměr:Časový bod:Moč:Kvantitativní:
de-AT	German (Austria)	Synonyms: Carnosin/Kreatinin-Ratio /U
el-GR	Greek (Greece)	Καρνοσίνη/Κρεατινίνη:SRto:Pt:Ούρα:Qn: Synonyms: CHEM Pt Qn SRto Καρνοσίνη Κρεατινίνη Ούρα
es-AR	Spanish (Argentina)	carnosina/creatinina:relación de concentración de la sustancia:punto en el tiempo:orina:cuantitativo:
es-ES	Spanish (Spain)	Carnosina/Creatinina:Relacion de Sustancia:Punto temporal:Orina:Qn: Synonyms: Cuantitativo
es-MX	Spanish (Mexico)	Carnosina / Creatinina:Proporción de sustancia:Punto temporal:Orina:Cuantitativo:
fr-CA	French (Canada)	Carnosine/Créatinine:Ratio de substance:Temps ponctuel:Urine:Quantitatif:
fr-FR	French (France)	Carnosine/créatinine:Moles ratio:Ponctuel:Urine:Numérique:
fr-BE	French (Belgium)	Carnosine/Créatinine:Ratio de substance:Temps ponctuel:Urine:Quantitatif:
it-IT	Italian (Italy)	Carnosina/Creatinina:Srto:Pt:Urine:Qn: Synonyms: Chimica Punto nel tempo (episodio) Rapporto di sostanza
ko-KR	Korean (Korea, Republic Of)	카르노신/크레아티닌:물질구성비:검사시점:뇨:정량:
nl-NL	Dutch (Netherlands)	carnosine/creatinine:molaire verhouding:moment:urine:kwantitatief: Synonyms: kreatinine
pl-PL	Polish (Poland)	Karnozyna/kreatynina:współczynnik molowy:punkt w czasie:mocz:ilościowy:
pt-BR	Portuguese (Brazil)	Carnosina/Creatinina:SCrto:Pt:Urina:Qn: Synonyms: Car; Creat; CR; sRto; Substance concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry; UCr
ru-RU	Russian (Russian Federation)	Карнозин/Креатинин:МольОтн:ТчкВрм:Моча:Колич: Synonyms: Количественный Мольная доля;Молярная доля;Отношение концентраций Точка во времени;Момент
tr-TR	Turkish (Turkey)	Karnozin/Kreatinin:SOrn:Zmlı:İdrar:Kant: Synonyms: SubsOranı
zh-CN	Chinese (China)	肌肽/肌酐:物质的量比率:时间点:尿液:定量型: Synonyms: Car;N-β-丙氨酰-L-组氨酸 CR;Creat;肌氨酸酐;肌酸内酰胺;肌酸酐 UCr 化学;化学检验项目;化学检验项目类;化学类;化学试验;非刺激耐受型化学检验项目;非刺激耐受型化学检验项目类;非刺激耐受型化学试验;非刺激耐受型化学试验类可用数量表示的;定量性;数值型;数量型;连续数值型标尺尿;小便;下泉尿液肌酐尿液肌酸酐尿肌酸酐时刻;随机;随意;瞬间物质的量比值;物质的量比;摩尔比;摩尔比率;摩尔比值肌酸内酰胺

Example Units

Unit	Source
mmol/mol	eCHN
mmol/mol{creat}	Example UCUM Units

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=26580-1

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.